Show source-provided references
1. GBD Chronic Kidney Disease Collaboration (2020). Global, regional, and national burden of chronic kidney disease, 1990–2017: A systematic analysis for the Global Burden of Disease Study 2017. Lancet, 395, 709–733.
2. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: Reference and alternative scenarios for 2016-40 for 195 countries and territories
10.1016/S0140-6736(18)31694-5 ↗3. Noce, A., Marrone, G., Wilson Jones, G., Di Lauro, M., Pietroboni Zaitseva, A., Ramadori, L., Celotto, R., Mitterhofer, A.P., and Di Daniele, N. (2021). Nutritional Approaches for the Management of Metabolic Acidosis in Chronic Kidney Disease. Nutrients, 13.
10.3390/nu13082534 ↗4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group (2024). KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney Int., 105, S117–S314.
10.1016/j.kint.2023.10.018 ↗5. The Kidney Disease Improving Global Outcomes (KDIGO) guideline update for chronic kidney disease: Evolution not revolution
10.1373/clinchem.2012.184259 ↗7. The progression of chronic kidney disease: A 10-year population-based study of the effects of gender and age
10.1038/sj.ki.5000058 ↗8. The natural history of chronic renal failure: Results from an unselected, population-based, inception cohort in Sweden
10.1053/j.ajkd.2005.07.040 ↗12. Canale, M.P., Noce, A., Di Lauro, M., Marrone, G., Cantelmo, M., Cardillo, C., Federici, M., Di Daniele, N., and Tesauro, M. (2021). Gut Dysbiosis and Western Diet in the Pathogenesis of Essential Arterial Hypertension: A Narrative Review. Nutrients, 13.
10.3390/nu13041162 ↗13. Is rasburicase an effective alternative to allopurinol for management of hyperuricemia in renal failure patients? A double blind-randomized study
14. Basilicata, M., Di Lauro, M., Campolattano, V., Marrone, G., Celotto, R., Mitterhofer, A.P., Bollero, P., Di Daniele, N., and Noce, A. (2022). Natural Bioactive Compounds in the Management of Oral Diseases in Nephropathic Patients. Int. J. Environ. Res. Public Health, 19.
10.3390/ijerph19031665 ↗15. Oxidative stress and inflammation, a link between chronic kidney disease and cardiovascular disease
10.1038/ki.2008.516 ↗16. Halitosis, reduced salivary flow and the quality of life in pre-kidney transplantation patients
10.4317/jced.57282 ↗17. Bidirectional Interaction Between Chronic Kidney Disease and Porphyromonas gingivalis Infection Drives Inflammation and Immune Dysfunction
10.1155/jimr/8355738 ↗18. Pathophysiology, therapy, and oral implications of renal failure in children and adolescents: An update
20. Studies on curcumin and curcuminoids. IX: Investigation of the photobiological activity of curcumin using bacterial indicator systems
10.1002/jps.2600760506 ↗21. Costacurta, M., Di Lauro, M., Cornali, K., Docimo, R., and Noce, A. (2025). Developmental Defects of Enamel and Dental Caries in Pediatric Patients with Chronic Kidney Disease–Mineral Bone Disorders. Appl. Sci., 15.
10.3390/app15031164 ↗23. Gasner, N.S., and Schure, R.S. (2025). Periodontal Disease, StatPearls.
24. Kozak, M., and Pawlik, A. (2023). The Role of the Oral Microbiome in the Development of Diseases. Int. J. Mol. Sci., 24.
10.3390/ijms24065231 ↗25. Bhuyan, R., Bhuyan, S.K., Mohanty, J.N., Das, S., Juliana, N., and Juliana, I.F. (2022). Periodontitis and Its Inflammatory Changes Linked to Various Systemic Diseases: A Review of Its Underlying Mechanisms. Biomedicines, 10.
10.3390/biomedicines10102659 ↗27. Fusobacterium nucleatum-infected periodontitis promotes renal interstitial fibrosis in rats through the TGF-beta/SMAD2/3 and beta-catenin signaling pathways
10.1016/j.gene.2024.148729 ↗28. Li, L., Zhang, Y.L., Liu, X.Y., Meng, X., Zhao, R.Q., Ou, L.L., Li, B.Z., and Xing, T. (2021). Periodontitis Exacerbates and Promotes the Progression of Chronic Kidney Disease Through Oral Flora, Cytokines, and Oxidative Stress. Front. Microbiol., 12.
10.3389/fmicb.2021.656372 ↗29. Periodontitis regulates renal impairment in obese mice via TGF-beta/Smad pathway
30. American Academy of Periodontology (2011). Comprehensive periodontal therapy: A statement by the American Academy of Periodontology. J. Periodontol., 82, 943–949.
10.1902/jop.2011.117001 ↗31. A new classification scheme for periodontal and peri-implant diseases and conditions—Introduction and key changes from the 1999 classification
10.1111/jcpe.12935 ↗35. Basilicata, M., Pieri, M., Marrone, G., Nicolai, E., Di Lauro, M., Paolino, V., Tomassetti, F., Vivarini, I., Bollero, P., and Bernardini, S. (2023). Saliva as Biomarker for Oral and Chronic Degenerative Non-Communicable Diseases. Metabolites, 13.
10.3390/metabo13080889 ↗36. Chronic treatment with statins increases the availability of selenium in the antioxidant defence systems of hemodialysis patients
10.1016/j.jtemb.2009.06.005 ↗37. Basha, M.M., Al-Kadasi, B.A., Al-Hajri, M., Al-Sharani, H.M., and Elayah, S.A. (2024). Exploring the correlation between periodontal disease and serum biomarkers in haemodialysis patients. BMC Oral. Health, 24.
10.1186/s12903-024-04826-1 ↗38. Dembowska, E., Jaron, A., Raslawska-Socha, J., Gabrysz-Trybek, E., Bladowska, J., Gacek, S., and Trybek, G. (2022). The Evaluation of the Periodontal Status of Hemodialysis Patients with End-Stage Renal Disease. J. Clin. Med., 11.
10.3390/jcm11040975 ↗40. Belluz, M., and Longhi, E. (2023). Periodontal Disease. Managing Psychosexual Consequences in Chronic Diseases, Springer International Publishing.
10.1007/978-3-031-31307-3_27 ↗41. Xerostomia in the Geriatric Patient: Causes, Oral Manifestations, and Treatment
43. Erythrocyte glutathione transferase activity: A possible early biomarker for blood toxicity in uremic diabetic patients
10.1007/s00592-013-0497-3 ↗